Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-31 Exercise | 2024-04-02 8:35 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,952 | $0 | 139,847 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 8:35 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 3,098 | $0.681 | 139,847 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 9,956 | $0 | 134,839 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 4,082 | $0.681 | 134,839 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 24,474 | $0 | 4,641,882 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,172 | $0.681 | 4,641,882 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:40 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,533 | $0 | 26,863 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:40 pm | N/A N/A | Monopar Therapeutics | MNPR | Brown Michael J Director | 2,533 | $0 | 4,513,803 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:39 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,952 | $0 | 142,945 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 7:39 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 3,098 | $0.3402 | 142,945 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:38 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,533 | $0 | 3,086,257 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,533 | $0 | 75,263 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 31,198 | $0 | 9,156,003 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 10,796 | $0.3402 | 9,156,003 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:34 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 11,188 | $0 | 234,477 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 7:34 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 4,578 | $0.3402 | 234,477 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 7:33 pm | N/A 2033-12-31 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,172 | $0.6199 | 4,659,850 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 24,474 | $0 | 4,659,850 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 3,444 | $0.6199 | 143,499 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 9,956 | $0 | 143,499 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:35 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,533 | $0 | 75,263 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:34 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,533 | $0 | 3,086,257 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:32 pm | N/A N/A | Monopar Therapeutics | MNPR | Brown Michael J Director | 2,533 | $0 | 4,513,803 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:31 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,533 | $0 | 26,863 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 7:30 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 2,624 | $0.6199 | 146,043 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:30 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,953 | $0 | 146,043 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:51 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 13,841 | $0 | 148,667 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 6:51 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,057 | $0.855 | 148,667 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:50 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,534 | $0 | 26,863 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:49 pm | N/A N/A | Monopar Therapeutics | MNPR | Brown Michael J Director | 2,534 | $0 | 4,513,803 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:49 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,534 | $0 | 3,086,257 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:46 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,534 | $0 | 75,263 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:46 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 14,846 | $0 | 146,943 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 6:46 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 5,104 | $0.855 | 146,943 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 35,039 | $0 | 4,667,022 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 6:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 10,269 | $0.855 | 4,667,022 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:21 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,533 | $0 | 75,263 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:20 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,533 | $0 | 3,086,257 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:19 pm | N/A N/A | Monopar Therapeutics | MNPR | Brown Michael J Director | 2,533 | $0 | 4,513,803 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:18 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,533 | $0 | 26,863 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 13,911 | $0 | 4,677,291 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,286 | $1.39 | 4,677,291 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:16 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 5,067 | $0 | 152,047 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:16 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 1,842 | $1.39 | 152,047 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,063 | $0 | 74,490 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,154 | $1.39 | 74,490 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:51 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | Anderson Raymond Director | 24,063 | $0 | 24,063 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:50 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | Brown Michael J Director | 24,063 | $0 | 24,063 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:49 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 390,851 | $0 | 548,746 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:47 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 24,063 | $0 | 24,063 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:45 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 180,922 | $0 | 238,070 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:44 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 180,922 | $0 | 229,672 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:43 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 24,063 | $0 | 24,063 (Direct) | View |
| 2022-12-31 Exercise | 2023-01-03 4:11 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,859 | $0 | 16,730 (Direct) | View |